> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# EUA for Indicaid Covid-19 Rapid Antigen Test
- URL: https://www.fdaweb.com/eua-for-indicaid-covid-19-rapid-antigen-test/
- Published: 2022-03-18T12:00:00.000Z
- Updated: 2026-09-14T17:37:04.000Z
- Author: David McFarland
- Tags: Devices, #legacy-id-D5151403

FDA has granted an emergency use authorization for an Indicaid Covid-19 over-the-counter at-home rapid antigen test. An agency [statement](https://content.govdelivery.com/accounts/USFDA/bulletins/30f54a4?ref=fdaweb.com) (contains a link to the emergency authorization document) says the test delivers results in 20 minutes.

The test can be used as **(1)** a single test for people in the first six days of Covid-19 symptom onset and **(2)** a serial test for people with or without symptoms, FDA says. It is authorized for those age 14 and older with a self-collected nasal swab sample and those age 2 and older when an adult collects the nasal swab sample.